These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30301150)

  • 1.
    Huang SY; Huang GJ; Wu HC; Kao MC; Huang WC
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30301150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese Herbal Medicine
    Huang WC; Chang MS; Huang SY; Tsai CJ; Kuo PH; Chang HW; Huang ST; Kuo CL; Lee SL; Kao MC
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis.
    Gu Y; Xue M; Wang Q; Hong X; Wang X; Zhou F; Sun J; Wang G; Peng Y
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948018
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR.
    Hsieh PF; Jiang WP; Basavaraj P; Huang SY; Ruangsai P; Wu JB; Huang GJ; Huang WC
    Phytomedicine; 2021 Dec; 93():153806. PubMed ID: 34740154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.
    Li X; Chen YT; Hu P; Huang WC
    Mol Cancer Ther; 2014 Apr; 13(4):855-66. PubMed ID: 24493696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
    Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
    Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
    Guan M; Fousek K; Chow WA
    FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression.
    Huang SY; Huang GJ; Hsieh PF; Wu HC; Huang WC
    Prostate; 2019 Sep; 79(13):1543-1552. PubMed ID: 31299104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
    Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
    PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Therapeutic Activity of
    Hsieh PF; Jiang WP; Huang SY; Basavaraj P; Wu JB; Ho HY; Huang GJ; Huang WC
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32276528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer.
    Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL
    Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.
    Huang WC; Li X; Liu J; Lin J; Chung LW
    Mol Cancer Res; 2012 Jan; 10(1):133-42. PubMed ID: 22064655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics.
    Hu B; Wang C; Wu Y; Han C; Liu J; Chen R; Wang T
    J Ethnopharmacol; 2024 Aug; 330():118228. PubMed ID: 38643863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.
    Huang WC; Zhau HE; Chung LW
    J Biol Chem; 2010 Mar; 285(11):7947-56. PubMed ID: 20071336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo.
    Petiwala SM; Li G; Bosland MC; Lantvit DD; Petukhov PA; Johnson JJ
    Carcinogenesis; 2016 Aug; 37(8):827-838. PubMed ID: 27267997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
    J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.